How HHS Recognizes that Vaccines Can Cause Encephalopathy

Prepared for clinicians, attorneys, policymakers, and the public.

The U.S. Department of Health and Human Services (HHS), through the Vaccine Injury Compensation Program (VICP), has formally and publicly recognized that encephalopathy—a serious neurological condition involving acute and chronic brain dysfunction—can be caused by specific vaccines. This recognition is not speculative or contingent. It is encoded in federal regulation, subject to rulemaking, supported by decades of epidemiologic data and scientific review, and reflected in how compensation claims are adjudicated in the U.S. Court of Federal Claims. This article walks through the legal foundation, clinical criteria, procedural mechanisms, and public health implications of HHS’s recognition of encephalopathy as a vaccine-induced injury under defined conditions. It is written to ensure clarity for attorneys handling vaccine injury cases, physicians who administer vaccines, parents navigating post-vaccine injury, and journalists covering vaccine law and safety.

What is Encephalopathy?

Under federal vaccine law, the term “encephalopathy” carries a specific and rigorously defined meaning. It refers to a significant acquired abnormality or dysfunction of the brain’s function, marked by altered consciousness, lethargy, or personality change lasting at least 24 hours, and, in many cases, followed by chronic neurologic impairment. The Code of Federal Regulations (42 C.F.R. § 100.3(b)(2)) provides an operational clinical definition for use in legal adjudication. For an injury to qualify, it must not be better explained by an alternative diagnosis such as metabolic disorder, trauma, or congenital anomaly. The regulatory definition recognizes both acute presentations—such as persistent decreased consciousness—and long-term sequelae, including cognitive, sensory, or motor dysfunctions.

Glossary

VICP: Vaccine Injury Compensation Program
VIT: Vaccine Injury Table
CFR: Code of Federal Regulations
Encephalopathy: Significant acquired brain dysfunction (as defined in 42 C.F.R. § 100.3(b)(2))
Presumption of Causation: A legal standard that shifts the burden of proof to the Secretary of HHS once statutory conditions are met.

For purposes of the Vaccine Injury Table, “encephalopathy” is not a vague synonym for “altered behavior after vaccination.” A vaccine recipient “shall be considered to have suffered an encephalopathy” only when an acute encephalopathy occurs within the applicable Table time period and results in a chronic encephalopathy. For children under 18 months, acute encephalopathy is indicated by a significantly decreased level of consciousness lasting at least 24 hours (with additional constraints if the event follows a seizure, including that the decreased consciousness cannot be attributed to a postictal state or medication). For adults and children 18 months or older, acute encephalopathy must persist at least 24 hours and must include at least two of the specified features (including a non‑medication‑related significant change in mental status; a significantly decreased level of consciousness independent of seizure and not attributable to medication; and/or a seizure associated with loss of consciousness). The regulation also states what does not qualify by itself (sleepiness, irritability, high‑pitched screaming, poor feeding, persistent crying, bulging fontanelle, dementia symptoms), and it provides exclusionary criteria: the condition is not a Table encephalopathy if shown to be caused by specified unrelated underlying conditions (e.g., malignancy, structural lesion, psychiatric illness, dementia, genetic disorder, prenatal/perinatal CNS injury) or unrelated acute events (e.g., head trauma, stroke/TIA, complicated migraine, drug use, infectious disease). A “chronic encephalopathy” requires persistence of the change in mental/neurologic status for at least 6 months from first symptom/manifestation; return to baseline in less than 6 months defeats the presumption of residual neurologic damage from that event.

Thus, in the VICP context, encephalopathy is not a vague post-event report of “feeling off” but rather a severe, documentable neurological outcome with strict diagnostic features. The Table provides not only this definition but also the critical timing and vaccine pairings necessary to invoke a legal presumption of causation.

The Vaccine Injury Table: Formal Legal Recognition of Causation

At the heart of the VICP lies the Vaccine Injury Table (VIT), a regulatory document incorporated into law at 42 C.F.R. § 100.3. This Table is more than a medical guideline; it is a causality construct. The inclusion of encephalopathy on the Table, linked to specific vaccines and time windows, signifies that HHS accepts, affirms, and encodes a causal relationship between those vaccines and that injury.

Covered Vaccines and Time Windows

These pairings are based on expert review panels convened under the Institute of Medicine (now the National Academy of Medicine), which conducted comprehensive causality assessments. Rulemaking follows a formal notice-and-comment process and requires consultation with the Advisory Commission on Childhood Vaccines (ACCV).

The Compensation Framework: Legal, Clinical, and Procedural Realities

The VICP is an administrative compensation system established by Congress under the National Childhood Vaccine Injury Act of 1986. Unlike civil tort litigation, it does not involve suing vaccine manufacturers or physicians. Instead, it provides a non-adversarial path to compensation for individuals injured by vaccines, drawing funds from a federal trust account financed by a per-dose excise tax of $0.75 on covered vaccines. As of early 2026, the VICP Trust Fund holds over $4.1 billion.

Claims are filed in the U.S. Court of Federal Claims and reviewed by a panel of eight Special Masters appointed for this purpose. When a claim involves an injury that appears on the Vaccine Injury Table and meets the defined timing and diagnostic thresholds, causation is presumed. That is, the burden of proof shifts to the government to rebut the claim by demonstrating, with a preponderance of evidence, that a factor unrelated to the vaccine was responsible for the injury.

Compensation includes past and future medical costs, lost earnings, pain and suffering (capped at $250,000), and attorney fees. When compensation is awarded, the special master/court must also award reasonable attorneys’ fees and costs. When compensation is not awarded, fees and costs are discretionary and require findings that the petition was brought in good faith and had a reasonable basis

Discovery is limited, and many cases are resolved more efficiently than traditional civil litigation. Off-Table claims, however, require expert medical testimony and full burden of proof.

Comparison: Table vs. Off-Table Claims

Why Table Inclusion Means Causality

There is a persistent misconception in media and even among some professionals that the presence of a condition on the Vaccine Injury Table merely reflects correlation or legal expedience. That is not the case. Under the Administrative Procedure Act, HHS cannot maintain a Table that is arbitrary or unsupported by evidence. The presence of encephalopathy on the Table reflects a settled administrative conclusion that, under specific circumstances, certain vaccines can cause this injury.

The legal presumption is not a procedural shortcut. It reflects the culmination of decades of surveillance data, published literature, mechanistic plausibility, and adjudication history. Removing or modifying such a Table entry would require equivalent evidentiary rigor. In that sense, presumed compensability is a proxy for affirmative causal recognition under U.S. federal law.

Clinical Implications for Physicians

Pediatricians and family physicians must understand that encephalopathy occurring after pertussis- or MMR-containing vaccination, within the defined windows, is legally presumed to have been caused by that vaccine unless proven otherwise. This has implications for future vaccination decisions, particularly when assessing contraindications. FDA-approved labeling for DTaP and Tdap vaccines explicitly states that a history of encephalopathy within 7 days of a previous dose is a contraindication to further doses. The CDC reaffirms this stance in its immunization guidance.

Physicians must also comply with mandatory reporting requirements under the VAERS system (42 U.S.C. § 300aa-25), which explicitly includes encephalopathy after vaccines like DTaP and MMR as reportable events within 7 or 15 days, respectively. Federal law requires reporting to the Secretary (operationalized through VAERS) of (A) events set forth in the Vaccine Injury Table and (B) contraindicating reactions specified in the manufacturer’s package insert. The VAERS Reportable Events Table implements that mandate and explicitly lists “Encephalopathy or encephalitis” as reportable within defined intervals for pertussis‑containing vaccines and MMR‑containing vaccines.

While most vaccine encounters are uneventful, clinicians must be prepared to address questions regarding serious adverse events like encephalopathy and include it in risk discussions.

Relevance to Vaccines and Autism

A 2011 comprehensive review of publicly available VICP decisions, stipulations, and related records by legal scholars Mary Holland, Louis Conte, Robert Krakow, and Lisa Colin examined compensated claims of vaccine-induced brain injury and identified 83 cases in which children who met the regulatory criteria for encephalopathy or residual seizure disorder also received diagnoses of autism or displayed prominent autism-like features. These features included acute developmental regression, loss of previously acquired language and social skills, impaired communication, repetitive behaviors, sensory abnormalities, and significant cognitive or behavioral challenges—symptoms that closely align with autism spectrum disorder criteria.

The authors highlighted 21 specific published decisions and case stipulations in a detailed case chart, many of which involved Table injuries with presumed causation: encephalopathy within 72 hours of pertussis-containing vaccines (e.g., DTP/DTaP) or within 5–15 days of MMR-containing vaccines.

A prominent example is the 2008 concession in the case of Hannah Poling, in which HHS acknowledged that administration of multiple vaccines significantly aggravated an underlying mitochondrial disorder, resulting in encephalopathy and subsequent “autism-like” developmental regression; the family ultimately received substantial compensation for past and future care. The authors noted that, while the VICP has consistently stated that it has never compensated a claim on the theory that vaccines cause autism as a distinct condition (a position reinforced in the 2009–2010 Omnibus Autism Proceeding), the program has in practice compensated dozens of encephalopathy cases whose long-term sequelae were described by clinicians, experts, and families in terms indistinguishable from autism.

These adjudicated outcomes provide concrete illustration of how the legal presumption of causation for Table-listed encephalopathy can extend to chronic neurodevelopmental impairment, albeit in an oblique and indirect manner.

Legal Implications for Attorneys and Petitioners

For legal professionals representing vaccine-injured clients, Table injuries provide a significantly more favorable path to compensation than off-Table claims. In the case of encephalopathy, attorneys should prioritize documenting the exact time of symptom onset, collecting detailed hospital records, and confirming the absence of alternate explanatory diagnoses. The presumption of causation afforded by the Table shifts the burden of disproof to the Secretary of HHS, effectively tilting the case in the petitioner’s favor if the regulatory definitions are met.

Even for Table injuries, cases can be denied if the timing is ambiguous, if documentation is incomplete, or if the clinical features fail to satisfy the definition. Attorneys must ensure that the encephalopathy claim is substantiated by clinical signs such as persistent lethargy, seizure activity, altered mental status, or documented developmental regression.

Attorneys should therefore frame claims around the Table criteria (encephalopathy) rather than broader diagnostic labels such as autism, which the program has consistently rejected as a standalone compensable injury. The VICP focuses on documented symptoms and functional impairment rather than specific diagnoses; when a vaccine causes harm that meets the regulatory definition of encephalopathy and its sequelae, compensation is owed regardless of the ultimate diagnostic label applied by clinicians.

Public Understanding: What This Recognition Does—and Does Not—Mean

HHS recognition of encephalopathy as a vaccine injury does not imply that vaccines frequently or generally cause these injuries. Their recognition represents the federal government’s commitment to fairness and transparency, not an indictment of vaccination as a whole.

By the same token, this recognition is not symbolic or rhetorical. It carries legal weight. When encephalopathy occurs in a child following a pertussis vaccine within 72 hours, and when the clinical record matches the regulatory criteria, HHS does not ask whether the vaccine was “likely” responsible—it accepts it. That recognition is foundational to the structure of the VICP and should be accurately reported by journalists and public health educators alike.

Reform Trajectory and International Context

The United States is not alone in offering compensation for vaccine injury, but it is unique in its hybrid structure—a federal trust fund administered through a judicial process. By contrast, most European and Asian nations integrate compensation into national health insurance or civil administrative courts. Recent calls for VICP reform have centered on updating the $250,000 cap on pain and suffering (which has not been adjusted for inflation since 1986), increasing the number of Special Masters, accelerating the Table update process, and modernizing jurisdictional mechanisms.

Final Thoughts

The federal government of the United States, through the Department of Health and Human Services, explicitly and affirmatively recognizes that certain vaccines can cause encephalopathy. This recognition is not symbolic, passive, or theoretical. It is operationalized in law, it is adjudicated in federal court, and it is built upon decades of scientific review. Vaccine adverse events addressed through a system that is not yet sufficiently designed to preserve public trust, scientific integrity, and legal consistency. However, encephalopathy’s inclusion on the Vaccine Injury Table represents one of the clearest examples of HHS policy aligning with both evidence and justice.

Citations

• 42 U.S.C. §§ 300aa-11, 300aa-13, 300aa-14

• 42 C.F.R. § 100.3

• HRSA. (2022). Vaccine Injury Table. https://www.hrsa.gov/sites/default/files/hrsa/vicp/vaccine-injury-table-01-03-2022.pdf

• FDA. (2022). KINRIX Prescribing Information. https://www.fda.gov/media/80128/download

• FDA. (2022). PEDIARIX Prescribing Information. https://www.fda.gov/media/79830/download

• CDC. Vaccine Adverse Event Reporting System (VAERS). https://vaers.hhs.gov

• Holland, M., Conte, L., Krakow, R., & Colin, L. (2011). Unanswered questions from the Vaccine Injury Compensation Program: A review of compensated cases of vaccine-induced brain injury. Pace Environmental Law Review, 28(2), 480–543. https://digitalcommons.pace.edu/pelr/vol28/iss2/6

• Institute of Medicine. (2012). Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press.

• Federal Register, Vol. 87, No. 92, May 13, 2022, pp. 29158–29161